Clinical Trial

Study of Longitudinal Observation for Patient With X-linked Hypophosphatemic Rickets/Osteomalacia in Collaboration With Asian Partners

Study acronym: SUNFLOWER
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Through observation of patients with X-linked hypophosphatemic rickets/osteomalacia (XLH) for up to 10 years, the study intends to collect data that allow achievement of the following objectives: 1. To determine medical characteristics of the disease and the disease process 2. To determine physical and psychological burden on patients as well as economic burden 3. To assess the efficacy and safety of the treatment of the disease
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2018-11-16; most recent amendment 2025-08-28.
Status change: Recruiting → Active, Not Recruiting 2023-02-13
Trial Details
NCT Number NCT03745521
Lead Sponsor Kyowa Kirin Co., Ltd.
Conditions X-Linked Hypophosphatemia
Enrollment 226 participants
Start Date 2018-05-01
Primary Completion 2028-12-31 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-09-05